Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin

Clinical trial NCT02420691 · COMPLETED

Trial details

NCT number: NCT02420691
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Digestive System Neuroendocrine Neoplasm Duodenal Neuroendocrine Tumor G1 Functional Pancreatic Neuroendocrine Tumor Gastric Neuroendocrine Tumor Intermediate Grade Lung Neuroendocrine Neoplasm Low Grade Lung Neuroendocrine Neoplasm Nonfunctional Pancreatic Neuroendocrine Tumor Thymus Neoplasm

Start date: 2015-08-25
Primary completion: 2019-06-05
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.